Background-Percutaneous coronary intervention (PCI) for stable coronary artery disease does not reduce the risk of death and myocardial infarction compared with optimal medical therapy (OMT), but many patients think otherwise. PCI Choice, a decision aid (DA), was designed for use during the clinical visit and includes information on quality of life and mortality outcomes for PCI with OMT versus OMT alone for stable coronary artery disease. Methods and Results-We conducted a randomized trial to assess the impact of the PCI Choice DA compared with usual care when there is a choice between PCI and optimal medical therapy. Primary outcomes were patient knowledge and decisional conflict, and the secondary outcome was an objective measure of shared decision making. A total of 124 patients were eligible for final analysis. Knowledge was higher among patients receiving the DA compared with usual care (60% DA; 40% usual care; P=0.034), and patients felt more informed (P=0.043). Other measures of decisional quality were not improved, and engagement of the patient by the clinician in shared decision making did not change with use of the DA. There was evidence that clinicians used the DA as an educational tool. Conclusions-The PCI Choice DA improved patient knowledge but did not significantly impact decisional quality. Further work is needed to effectively address clinician knowledge gaps in shared decision-making skills, even in the context of carefully designed DAs. Clinical Trial Registration-URL: https://www.clinicaltrials.gov/. Unique identifier: NCT01771536.
A lthough percutaneous coronary intervention (PCI) has not been shown to reduce the risk of death and myocardial infarction (MI) for stable coronary artery disease (CAD) when compared with optimal medical therapy (OMT) alone, 1,2 most patients continue to think that PCI for stable CAD is a life-saving procedure. 3 PCI for stable CAD is known to improve patients' quality of life more rapidly than medications, 4 and thus, the primary indication for PCI is symptom relief. 5 There is evidence that clinical practice has changed little after publication of research demonstrating equipoise between OMT and PCI for stable CAD. 6 There is also a percentage of elective PCIs that are performed each year that are judged to be rarely appropriate because of an absence of symptoms or use of antianginal medications. 7 Although it is not clear whether this is primarily because of patient or physician preference, there is consistency in patient misperception of the benefit of PCI. 8 The treatment of stable CAD represents a preferencesensitive decision with comparable, alternative treatments. Shared decision making (SDM), as a "process of interacting with patients who wish to be involved in arriving at an informed, values-based choice among…medically reasonable alternatives," 9 offers a unique approach to healthcare delivery of patients with stable CAD. Decision aids may help clinicians engage patients in making deliberate choices by providing accessible information about the options available and the associated outcomes, and evidence exists that decision aids increase knowledge, reduce decisional conflict, and lead to greater patient involvement in decision making. 10 Previous work suggests that in-visit tools, developed with user-centered design methods and delivered by clinicians, may lead to greater patient involvement. [11] [12] [13] However, consistent clinician engagement is lacking and implementation of SDM is low, likely because of an interplay of a paternalistic culture, clinician educational gaps, and few decision aids that are easy to use during the clinic visit. 14 In response to data that patients misinterpret the benefit of PCI for stable CAD, 3 we designed a decision aid (PCI Choice) to be delivered by clinicians for use during the clinical visit when there was a choice to be made between OMT and PCI. 15 The decision aid was delivered upstream from diagnostic coronary angiography in recognition of high rates of ad hoc PCI, during which PCI is performed in the same setting as diagnostic angiography under moderate sedation. In current practice, there is variability among cardiologists; some prefer to define coronary anatomy via a diagnostic cardiac catheterization before allowing patients to participate in SDM for stable angina. In recognition of this, we designed a randomized trial of patients with stable CAD who are faced with a choice of OMT and PCI, regardless of whether diagnostic cardiac catheterization is planned. The decision aid was intended to help increase patient knowledge regarding the differences between the 2 therapeutic options. We hypothesized that use of the decision aid would increase patient knowledge and reduce decisional conflict when compared with usual care (UC).
Methods
This was a single-center, patient-level parallel designed, randomized (1:1) trial. The aim was to determine the efficacy of the PCI Choice decision aid for the primary outcomes of knowledge transfer and decisional conflict. The Mayo Clinic Institutional Review Board approved all study procedures, and clinicians and patients who participated provided written informed consent.
Setting and Recruitment
Regional presentations were held on the PCI Choice decision aid with input from local internists and family medicine providers. They expressed discomfort with partnering with a patient to make a final decision regarding an invasive cardiac procedure. Thus, patients were recruited from the outpatient cardiology practices at Mayo Clinic Rochester. Rochester, Minnesota, is a small city of >100 000 people with a large, regional catchment area for patients with stable angina. We felt this appropriate for this study and benefited from the large number of clinicians available to reduce contamination. Patients who were referred from great distance to Mayo Clinic after completed decision making with their local cardiologist to undergo PCI were not considered to have clinical equipoise and thus were not enrolled in the study.
Patient recruitment took place in 2 distinct locations: within the general cardiology clinic, located at the outpatient campus, and the interventional cardiology clinic, located in the same hospital as the cardiac catheterization laboratory (CCL). Inclusion criteria were broad enough to allow patients to be entered into the study from 2 different clinical contexts: one in which the decision for diagnostic cardiac catheterization had not yet been made, and the other in which diagnostic catheterization was planned and a decision was being made regarding ad hoc PCI. Notably, there was not a requirement for clinicians to obtain a diagnostic angiogram; rather, they were instructed to follow their standard practice in patient management, ideally enriched with patient preferences. The CCL has an annual PCI volume of 1400 cases, of which only one-third are for stable disease (≈420 cases per year). A significant proportion of patients seen for stable CAD with a choice of PCI versus OMT were not eligible because of the study team missing the specific clinic visit in which the decision was made (either because of timing or referral pattern). Highly specialized CCL physician extenders, before the study, had a precedent of meeting with patients who were scheduled to undergo diagnostic catheterization on request from the referring physician to discuss procedural details, the role of ad hoc PCI, and to communicate risks and benefits and review stent selection. Thus, they were included as clinicians in this study.
The study coordinator (S.D.) and principal investigators (M.C., H.H.T.) obtained informed consent from eligible patients and participating clinicians. The study coordinator then randomized the patient to UC versus decision aid (Figure 1) , with a dynamic allocation balanced across sex and presence of type 2 diabetes mellitus. 16 The randomization took place on a secure study website using a computer-generated allocation sequence, which randomized patients in a concealed fashion to decision aid versus UC. Blinding was not possible for patients and involved clinicians, given physical presence of the decision aid. Per the original study design, the principal investigators did not enroll any patients they were personally treating to eliminate bias in patient selection and potential coercion. The principal investigators did assist in delivery of UC or the decision aid in a small number of patients when the referring clinician was unavailable per his or her request. Per institutional practice, interventional cardiologists reviewed the electronic medical record before cardiac catheterization to determine decision making by referring clinician and patient regarding PCI for stable angina. If a note was not yet available, the referring clinician or the PI communicated the patient preference directly to the interventional cardiologist.
Patients
The patients included in this trial were adults (aged ≥18 years) who were considered candidates for both OMT and PCI for the treatment
WHAT IS KNOWN
• Patients misperceive the benefits of percutaneous coronary intervention for stable angina, with a belief that stents will reduce their risk of heart attack and save their life. • Decision aids are shown to improve patient knowledge and satisfaction, with inconsistent data regarding their ability to promote shared decision making.
WHAT THE STUDy ADDS
• Use of a decision aid by a clinician to discuss treatment options for stable angina during the clinical visit improves patient knowledge and increases patients' feelings of being informed. • Evaluation of recorded visits suggests that the decision aid was used as a patient education tool by clinicians; formal measures of shared decision making remained low when compared with usual care. • Decision aids increase patient knowledge but do not necessarily result in a shared decision-making process. Further work is needed to address clinician knowledge gaps in shared decision-making skills.
of stable CAD by the referring clinician. They did not have major barriers to providing consent or participating in SDM (ie, severe vision or hearing impairment, cognitive impairment, non-English speaking) and indicated availability for 3-month follow-up. In addition, one of the following was required to be present to be considered eligible: Canadian Cardiovascular Society (CCS) class I-III angina; stable post-MI patient considered for a staged procedure; or objective evidence of myocardial ischemia. Patients who were either (a) considering whether to pursue diagnostic cardiac catheterization or (b) those with planned diagnostic catheterization and were deciding on ad hoc PCI, were included. Known coronary anatomy was not required before randomization nor were specific medications in the treatment of stable angina, respecting individualized practice patterns. Exclusion criteria included the following: the presence of unstable angina or acute MI; ejection fraction <30%; markedly positive stress test (stage I Bruce with severe ST depressions or hypotension); known unprotected left main stenosis of >50%; severe 3 vessel disease that includes ≥70% stenosis in the proximal left anterior descending coronary artery; a reason for cardiac surgery; or excessive bleeding risk precluding use of aspirin and oral P2Y12 antiplatelet therapy.
Intervention
The decision aid arm included use of a paper-based decision aid that was stratified by angina type (CCS class I-II angina versus class III angina; Figure 2A and 2B). The decision aid was designed with a user-centered approach for use during the clinical encounter (in-visit), and its development is described elsewhere. 15 Training sessions were given on the decision aid to all participating clinicians in the form of several grand round presentations and at the time of initial consent into the study. In addition, the study coordinator and principal investigator offered just-intime training before each visit to review decision aid content and recommendations for its use; this took 1 to 3 minutes. A video was created demonstrating use of the decision aid and was available for viewing. 17
Statistical Analysis
All analyses were conducted according to the intention-to-treat principle. 18 Comparisons between arms were conducted using the t test for continuous outcomes. Categorical comparisons were conducted using the χ 2 test or the Fisher exact test, as appropriate. Unless noted, the test used is the χ 2 . All analysis was estimated in SAS 9.2 (Cary, NC). All P values are 2-sided unless noted (sample size calculation described below) and considered significant at <0.05 level. Patients with missing outcome data were not included in assessment of that outcome. We compared the incidence of missing data for each outcome between study arms and found no significant difference.
The primary outcomes were patient knowledge and decisional conflict. Consistently, only 12% of patients report that PCI for stable CAD does not reduce the risk of MI compared with OMT alone. 3 We expected a 25% increase in specific knowledge from 12% in UC arm to 37% in the decision aid arm. Using a 1-sided test with α of 0.05, we had 89% power to detect a difference with a sample size of 55 patients per arm (n=110). Patients' knowledge was assessed immediately after the visit (Material in the Data Supplement). The primary end point of patients' knowledge included 2 measurements: total correct out of 10 questions and specific knowledge that PCI does not reduce risk of MI compared with OMT alone (ie, Getting a stent for stable coronary artery disease will reduce my risk of heart attack or death when compared with medicines alone).
The Decisional Conflict Scale, a measure of personal perceptions of effective decision making, was used to ascertain decisional quality. 13, 19, 20 Note that a lower number on the Decisional Conflict Scale indicates less decisional conflict. In a previous trial of a decision aid for patients presenting with chest pain to the emergency department, the average decisional conflict score in the control arm was 35.9 (SD, 21.1) and the decision aid arm, 22.3 (SD, 18.9). 12 We had 94% power to detect a 13-point difference in decisional conflict with a 2-sided test and α of 0.05. 20 The overall Decisional Conflict Scale and subscales were reported on a 100-point scale; once again, lower scores indicated less decisional conflict.
Using audio or video recordings of the visits (performed with informed consent from all involved), the presence of SDM was assessed using the Observing Patient Involvement in Decision Making (OPTION) scale. This is a validated instrument in which recordings are assessed by trained, third-party observers for the healthcare provider's level of expertise for 12 key patient-involving behaviors and translated to a 0 to 100 scale 21 (Material in the Data Supplement). A recent review of studies utilizing the OPTION12 tool showed a mean score of 23% (SD, 14) when no intervention was used to promote SDM and a score of 32% (SD, 8) when interventions were deployed. Scores ranged from 3% to 50% across all studies. 22 Two trained observers rated clinicians based on evidence of activities, such as, the clinician states that there is more than one way to deal with the identified problem (equipoise) and the clinician checks that the patient has understood the information. Recordings were also assessed to determine whether the decision aid was used as intended (fidelity) and whether there was contamination in the UC arm (replication of key aspects of the decision aid). 11 Two independent reviewers from the trial evaluated 31 of the 58 videos in duplicate for both these end points. The agreement between reviewers for the OPTION scale and fidelity to decision aid content was assessed using the Lin concordance correlation coefficient, as well as the Bland-Altman analysis. 23, 24 
Results

Patient and Clinician Characteristics
A total of 132 patients were enrolled in the trial between December 2012 and March 2014. Of the 132 enrolled patients, 8 were excluded postrandomization for reasons, such as patient withdrawal and lack of angina on further history, which left 124 patients evaluable for analysis.
Patient characteristics are shown in Table 1 . The patient population was primarily male (73%) and white (98%) with class II angina (50%). Mean age was 68 years. There were no significant differences in any of the baseline characteristics. Although not statistically significant, there was a higher percentage of college graduates in the UC arm (28% UC versus 9% decision aid) and a lower percentage of both 2-year college graduates (33% UC versus 42% decision aid) and those without a high school diploma (2% UC versus 9% decision aid; P=0.064 for overall comparison). Income levels among included patients were diverse, but did not differ between the groups. There was an even mix of private insurance and Medicare, and few patients were covered by Medicaid.
A majority of patients were recruited from the interventional cardiology clinic (85%) and the remainder from the general cardiology clinic (15%).
Clinician characteristics are shown in Table 2 . Noninvasive cardiologists were prominent (47%) followed by interventional cardiologists and CCL physician extenders (25% each). Less than half of all patients (49%) were enrolled by a physician extender after an initial visit with a referring cardiologist. Clinicians had a mean of 10 years in practice. During the training process, both in large group settings and during just-in-time training, most physicians consistently reported that they felt they already performed SDM on a consistent basis. 
Primary Outcomes: Knowledge and Decisional Conflict
The primary outcome of patient knowledge was significantly improved; patients were more likely to understand that PCI does not reduce the risk of MI or death compared with OMT for stable CAD if exposed to the decision aid compared with UC (60.3% decision aid versus 39.6% UC; P=0.034; Table 3 ). The expanded patient knowledge measurement was also significantly higher in the decision aid arm, with patients answering an average of 65.1% of the questions correctly versus 42.7% in the UC arm (P<0.001). The decision aid significantly improved the degree to which patients felt informed regarding their choices (decisional conflict score in decision aid arm: 15.4 versus UC: 21.9; P=0.043); overall decisional conflict was not different between the 2 arms.
Secondary Outcome: SDM
The recorded visits assessed the extent to which the clinician engaged their patient in SDM using the OPTION scale.
Because of the fact that less than half of clinic visits were recorded (decision aid: 34/65, 52%, and UC: 20/59, 37%, total 45%), these results are deemed hypothesis-generating only, and subgroup analyses were not performed. Reasons for a lack of recording were not formally documented and ranged from clinician, patient, or family preference or lack of availability of recording equipment because of simultaneous patient enrollment. Two independent reviewers from the trial evaluated 31 of the 54 videos in duplicate for both these end points to ensure that agreement was sufficient before individual review. The agreement between reviewers for the OPTION scale for Lin concordance correlation coefficient was 0.85 (95% confidence interval [CI], 0.76 to 0.95) and the Bland-Altman analysis 95% limits for agreement ranged from −3.2 to 4.9 with a correlation between difference and mean of −0.178. For the fidelity checklist, the Lin concordance correlation coefficient was 0.85 (95% CI, 0.74 to 0.95) and the Bland-Altman analysis 95% limits for agreement ranged from −2.9 to 2.7 with a correlation between difference and mean of 0.036.
Assessment of SDM
There was no difference in the extent to which clinicians engaged patients in SDM as determined using the OPTION scale on recorded visits, and overall scores were low (decision aid 21.3% versus UC 16.0%; mean difference 5.2%; 95% CI, −0.5 to 10.9; P=0.071). Notably, 2 aspects of SDM were more likely to be present with the decision aid than UC: the clinician explains the pros and cons of options to the patient; and the clinician lists options, which can include the choice of no action (decision aid versus UC, P=0.029 and P<0.001, respectively). This is in contrast to low scores in 7 of the 12 items, which evaluate a clinician's interpersonal skills to engage patients in the decision-making process. These items included items, such as the clinician assesses patient's preferred approach to receiving information to assist decision making; the clinician explores the patient's expectations (or ideas) about how the problem(s) are to be managed; and the clinician elicits the patient's preferred level of involvement in decision making. The mean duration of the clinical visits was 24 minutes, ranging from 5 to 60 minutes. Both decision aid and UC visits took a similar amount of time, and no significant correlation was observed between the visit length and the OPTION scores (P=0.060).
The fidelity score indicates whether the decision aid was actually used as intended during the visit. The percentage of prespecified items covered in the decision aid arm was high, suggesting consistent use (70.9%; 95% CI, 63.8 to 79.0). Most of the clinicians participating in the study used the decision aid fewer than 5 times (69.2%), with an average use of 2 times, limiting concern of contamination. This was examined with an objective measure using the fidelity score, identifying that while clinicians in the UC arm discussed some points present in the decision aid (50.6%; 95% CI, 40.0 to 61.2), significantly fewer items were covered than when the decision aid was actually available (P=0.004).
Discussion
The use of an in-visit decision aid, PCI Choice, improved patient understanding that PCI for stable CAD does not reduce heart attack and death. Patients were more likely to feel informed with use of the decision aid compared with UC, and yet, other measures of decisional conflict (the level of uncertainty patients feel about their decision) and the presence of SDM were unchanged. Thus, a stable angina decision aid delivered by clinicians improved patient education but did not significantly impact decisional quality.
This trial has several important implications. First, this is an innovative approach to promote patient engagement by their clinicians before cardiac catheterization, as previous research has focused on scripts or decision aids delivered outside the clinical encounter. [25] [26] [27] Second, this trial supports previous findings that tools designed to improve patient understanding are unlikely to empower patients to create a shared decision visit with their specialist. 14, 28 Finally, in the context of an increasing focus on decision aids, [29] [30] [31] [32] this trial suggests that decision aids alone may be insufficient to promote SDM without prompts for specific clinician behaviors. Thus, this trial directs further research toward effective strategies for clinician engagement and skill development in SDM.
SDM is the process in which patients and their clinicians select treatment strategies together that best reflect the patient's preferences and values. 30 Professional societies and government agencies increasingly call for clinicians to engage their patients in SDM with minimal guidance on how best to implement this recommendation. [29] [30] [31] Previous efforts to promote SDM have largely focused on the patient, with most decision aids designed for patients to review on their own. 10 Although there is strong evidence that decision aids for patients improve patient knowledge, there are limited data that they empower patients to actively participate in decision making, 10, 14 and barriers to implementation are well documented to rest with the clinician. 10, 33, 34 The failure to improve decisional quality and SDM in this trial supports the hypothesis that effective patient engagement involves specific clinician behaviors that are learned or prompted. 35, 36 This raises the question of whether an intervention must include more deliberate methods to alter clinicians' current healthcare delivery patterns to lead to elicitation and integration of patient values and preferences. Many clinicians feel they already perform SDM regularly; yet, data suggest that attitudes are often not aligned, 35, 36 and there is little evidence of proficiency in SDM skills. 37 Importantly, the high scores on 2 items from the OPTION scale that focused on patient education suggested that the decision aid was often used as an educational pamphlet rather than a tool to facilitate a shared conversation. This trial suggests that although specialists may report that they already perform SDM, this may be because of a gap in knowledge of how this process is distinct from patient education. Future interventions to promote SDM must be targeted at clinicians, and their skills in SDM, as well as patients. 38, 39 
Study Limitations and Strengths
Our trial strengths include the rigorous development of the decision aid utilized, the randomized trial design, and the participation of a large number of clinicians, resulting in average use of the decision aid <3 times. Detailed analysis of the recorded visits suggested high fidelity of decision aid delivery and did not demonstrate evidence of contamination. However, there may be a learning curve for using a decision aid effectively in clinical practice, thus limiting the development of SDM behaviors.
A limitation to the applicability of our study findings includes placement within a referral practice. Low levels of decisional conflict were observed, perhaps the result of this referral process; enrolled patients likely had multiple conversations before meeting with either an interventional cardiologist or a CCL physician extender. However, patient knowledge was poor even in the context of multiple clinician visits, suggesting room for improvement in the care process. Finally, incorporation of decision aids for stable angina remains challenging within the practice of ad hoc PCI. It may be that our study design, which included patients already scheduled for cardiac catheterization as opposed to following a diagnostic procedure, influenced the degree to which patients were willing to reconsider a previous decision. Given high rates of ad hoc PCI nationally, however, use of the decision aid before diagnostic cardiac catheterization reflects standard of care. 40
Conclusions
The PCI Choice decision aid improved patient knowledge but did not significantly impact decisional quality, with evidence of clinicians using the tool for patient education without preference elicitation. Further work is needed to effectively address clinician knowledge gaps in SDM skills.
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